Owlet (OWLT) announced that the Central Drugs Standard Control Organization approved Dream Sock for distribution. This marks a significant milestone for the company as it now prepares to launch its integrated monitoring devices across India in early 2026. With approval from the CDSCO, India’s national regulatory body for cosmetics, pharmaceuticals, and medical devices, Owlet becomes one of the few infant health technology companies to meet the region’s medical device requirements.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OWLT: